Investigational Site Number 804014

Kharkiv 61002

0 studies enrolling now · 1 studies all time

What they study most

Hypercholesterolemia

Studies at this site

• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed